This activity focuses on one of the most persistent challenges in global hepatitis management: ensuring that patients who test positive for hepatitis B (HBV), hepatitis C (HCV), or hepatitis D (HDV) are successfully connected to ongoing care. Despite the availability …
The final program in the Linking Knowledge to Action: Empowering HCPs in Screening and Treatment of Patients Across the Viral Hepatitis Spectrum series focuses on practical and equitable approaches to meeting the World Health Organization’s 2030 hepatitis elimination targets. This …
Hospitalized patients with SARS-CoV-2 infection remain at significant risk of clinical deterioration and death, particularly among those with comorbidities or requiring advanced respiratory support. Despite evolving therapeutic options and published clinical guidelines, real-world implementation of SARS-CoV-2 treatment recommendations remains inconsistent, …
Timely diagnosis and prompt initiation of treatment are critical for optimizing outcomes in patients with SARS-CoV-2 infection. Yet, despite advancements in testing and therapeutic strategies, diagnostic delays and clinical missteps persist within the inpatient setting, potentially leading to worsened prognosis …
Spanish-speaking populations in the United States often face significant disparities in health care access, quality of communication, and health outcomes. A key driver of these disparities is a lack of culturally and linguistically competent communication between healthcare providers and patients. …
This program highlights the essential role of shared decision-making (SDM) and motivational interviewing in caring for individuals with or at risk for hepatitis B (HBV), hepatitis C (HCV), and hepatitis D (HDV). Moving beyond traditional paternalistic models of care, SDM …
Latine patient populations represent a rapidly growing and diverse segment of the U.S. healthcare landscape. Cultural beliefs, traditional healing practices, community influences and variable levels of trust in the healthcare system can significantly influence attitudes toward illness, medication use, and …
When adopting a comprehensive approach to improving the health of patients with idiopathic hypersomnia (IH) or narcolepsy, it is essential for clinicians to consider the interplay between cardiometabolic (CM), neurologic, and psychiatric comorbidities. Clinicians must prioritize educating both themselves and …
Obesity affects more than 44% of post-9/11 U.S. Veterans—far surpassing rates in the general population—and contributes substantially to cardiometabolic disease, osteoarthritis, chronic pain, sleep apnea, and type 2 diabetes. Despite strong evidence supporting effective treatments, clinical uptake remains suboptimal. Fewer …